Undersøgelserne var planlagt til at vare indtil to år, men kun den ene undersøgelse var gennemført på det tidspunkt, da lægemidlet blev vurderet.
The studies were designed to last up to two years, but only one of the studies had been completed by the time the medicine was assessed.